key: cord-0781252-bc1pst7n
authors: Beenen, L.F.M.; Bos, L.D.; Scheerder, M.J.; Lobé, N.H.J.; Muller, M.C.A.; Schultz, M.J.; van den Aardweg, J.G.; Goorhuis, A.; Bonta, P.I.; Middeldorp, S.; Vlaar, A.P.
title: Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
date: 2020-08-22
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.08.026
sha: e9d51a4141c9f166038d724d24be11b113da0247
doc_id: 781252
cord_uid: bc1pst7n

nan

Dear Editors, It is unclear why some patients with progression to severe COVID-19 pneumonia require admission to an intensive care unit (ICU) for invasive mechanical ventilation while others can be managed with supplementary oxygen on the ward. [1] Several hypotheses have been proposed to explain the differences in clinical course between patients. One hypothesis is that pulmonary embolism results in severe hypoxemia.

Observational studies suggest a high incidence of deep vein thrombosis in COVID-19, up to 25% in ICU patients compared to 6.5% in ward patients [2] , which may progress to pulmonary embolism. Pulmonary edema as a result of dysbalance of the bradykinin-kallikrein system is also suggested to contribute. [3] Another hypothesis is the onset of local thrombosis in the pulmonary microvasculature due to an inflammatory thrombotic microangiopathy. [4] We hypothesized that patients requiring invasive mechanical ventilation for COVID- (Table) .

CT Severity points (max20; mean, SD) 17.7 (2.0) 8.5 pneumonia, [4] although the extent of the perfusion defects is much more evident in this present study.

The strength of our study is that all patients underwent advanced imaging using a high-end dual source CT-scanner dedicated to COVID-19 patients. This limits the chance of measuring artifacts, although even then technical challenges remain. Our J o u r n a l P r e -p r o o f study also has several limitations. First, this is a single center study using a cross sectional design which does not allow to make any causal inferences with regard to the pathophysiology or order of events. Although basis for suspicion of PE was the same, as for the ICU patients evaluation was ordered primarily on clinical grounds and mostly at a later stage, and for the ward patients according to the YEARS-criteria mostly (but not always) at presentation, we cannot exclude confounding differences between the two groups. Second, we used semi-quantitative scores for single pass CT perfusion evaluation. Quantitative measurements for image analysis require a time-consuming procedure, and also are not validated for the investigated questions.

Next, we did not prospectively calculate the dead-space and shunt fractions in the included patients and were unable to link the imaging results with gas-exchange.

Finally, we cannot assess the impact of positive pressure ventilation on the observed perfused blood volumes and perfusion defects. Although the effect of positive pressure ventilation on lung perfusion is well known, little data is available on the changes in regional perfusion defects like we observed.

In 

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT, The Lancet. Infectious diseases

Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study

R. Society, CO-RADS -A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia